Evidence map›Paper›PMID 40646041›Full record

ArticleScientific reports2025

Colorimetric chemosensing of Riboflavin using polymeric micro-array reinforced by silver nanoparticle: State-of-the-art on one-drop biomedical analysis.

Farnaz Bahavarnia, Milad Baghal Behyar, Azadeh Nilghaz, Mohammad Hasanzadeh, Nasrin Shadjou

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Farnaz BahavarniaNutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Milad Baghal BehyarAsian Nano Ink Science Based Company, Tabriz University of Medical Sciences, Tabriz, Iran.
Azadeh NilghazDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 3052, Australia.
Mohammad HasanzadehPharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. hasanzadehm@tbzmed.ac.ir.
Nasrin ShadjouDepartment of Nanotechnology, Faculty of Science and Chemistry, Urmia University, Urmia, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Riboflavin, vitamin B2, is an essential micronutrient involved in energy metabolism and cellular function, making its monitoring crucial for clinical diagnostics, food quality control, and nutritional research. In this study, a parafilm-based micro-array was fabricated and utilized for colorimetric detection of riboflavin using triangular silver nanoparticles (TA-AgNPs) as an optical probe. The interaction between riboflavin and silver nanoparticles induced changes in the NPs' localized surface plasmon resonance (LSPR), resulting in a visible color change. This phenomenon was systematically studied by varying riboflavin concentrations and observing the corresponding optical response using UV-Vis spectroscopy. Riboflavin was detected in human plasma samples using CMYK colorimetric integrated digital image analysis by smartphones with a linear detection range of 0.1 to 100 mM and low limit of quantification of 0.1 mM in the standard solution of analyte. Using the unique plasmonic properties of TA-AgNPs and the construction simplicity of parafilm-based micro-array system, we aimed to provide a cost-effective, portable, and efficient method for riboflavin detection. The proposed platform has the potential to develop point-of-care diagnostics and on-site testing by offering a robust alternative to traditional laboratory-based analytical techniques and well plates.

Indexed as

ColorimetryMetal NanoparticlesRiboflavinSilverHumansLimit of DetectionPolymersSurface Plasmon ResonancePolymersRiboflavinSilverBiomedical analysisColorimetric chemosensorMicro-fabricationOptical monitoringRiboflavin

Identifiers

PMID40646041
PMCPMC12254227

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.